Key statistics
On Tuesday, Immunovia AB (publ) (IMMNOV TO 2:STO) closed at 0.0756, -24.40% below its 52-week high of 0.10, set on Sep 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.0798 |
---|---|
High | 0.0798 |
Low | 0.063 |
Bid | 0.066 |
Offer | 0.0756 |
Previous close | 0.0799 |
Average volume | 184.74k |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Nov 12 2024 17:00 GMT.
More ▼
Press releases
- Invitation to Immunovia's Q3 presentation
- Immunovia presents data from model development study at meeting of the PRECEDE pancreatic cancer research consortium
- Immunovia has successfully acquired all blood samples required to clinically validate its next-generation test for pancreatic cancer
- Immunovia completes analytical validation of its next-generation pancreatic cancer test
- Change in number of shares and votes in Immunovia AB (publ)
- Immunovia presents data from model development study at 2024 AACR Advances in Pancreatic Cancer medical conference
More ▼